Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients.

Hafez G, Malyszko J, Golenia A, Klimkowicz-Mrowiec A, Ferreira AC, Arıcı M, Bruchfeld A, Nitsch D, Massy ZA, Pépin M, Capasso G, Mani LY, Liabeuf S, CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target)

Open source

DOI: 10.1093/ckj/sfad239
Published: 2023 Dec
Container: Clinical kidney journal
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ckj/sfad239,
  title = {Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients.},
  author = {Hafez G and Malyszko J and Golenia A and Klimkowicz-Mrowiec A and Ferreira AC and Arıcı M and Bruchfeld A and Nitsch D and Massy ZA and Pépin M and Capasso G and Mani LY and Liabeuf S and CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target)},
  year = {2023},
  journal = {Clinical kidney journal},
  doi = {10.1093/ckj/sfad239},
  url = {https://doi.org/10.1093/ckj/sfad239}
}

RIS

TY  - JOUR
TI  - Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients.
AU  - Hafez G
AU  - Malyszko J
AU  - Golenia A
AU  - Klimkowicz-Mrowiec A
AU  - Ferreira AC
AU  - Arıcı M
AU  - Bruchfeld A
AU  - Nitsch D
AU  - Massy ZA
AU  - Pépin M
AU  - Capasso G
AU  - Mani LY
AU  - Liabeuf S
AU  - CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target)
PY  - 2023
JO  - Clinical kidney journal
DO  - 10.1093/ckj/sfad239
UR  - https://doi.org/10.1093/ckj/sfad239
ER  -

APA

G, H., J, M., A, G., A, K., AC, F., M, A., A, B., D, N., ZA, M., M, P., G, C., LY, M., S, L., & Target), C. A. (. D. I. N. E. C. (2023). Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients.. Clinical kidney journal. https://doi.org/10.1093/ckj/sfad239

Source records

pubmed · retrieved 2026-09-25T07:37:37.958Z